Mylan Asks High Court To Review Generics Rulings
Mylan Pharmaceuticals Inc. has asked the U.S. Supreme Court to review its loss in a patent infringement suit over generic hypertension drugs, claiming that a federal appeals court has established a...To view the full article, register now.
Already a subscriber? Click here to view full article